HIV Clinical Trials in New York, New York
30 recruitingNew York, New York
Showing 1–20 of 30 trials
Recruiting
Phase 2
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
HIV InfectionAnal Squamous Cell CarcinomaStage II Rectal Cancer AJCC v8+7 more
National Cancer Institute (NCI)40 enrolled14 locationsNCT04929028
Recruiting
Not Applicable
Ending the HIV Epidemic for Patient and Healthcare Staff Well-being
HIVWell-Being, PsychologicalStigma
Columbia University1,000 enrolled1 locationNCT05785169
Recruiting
Phase 3
A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1
HIV Infections
ViiV Healthcare332 enrolled89 locationsNCT06694805
Recruiting
Phase 3
Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)
HIV Pre-Exposure Prophylaxis
Gilead Sciences350 enrolled31 locationsNCT07047716
Recruiting
Not Applicable
MyPEEPS LITE Trial
HIV/AIDS
Columbia University3,200 enrolled2 locationsNCT06741631
Recruiting
Not Applicable
WiseApp for Spanish Speakers Living With HIV
HIV InfectionsAcquired Immune Deficiency SyndromeSexually Transmitted Diseases, Viral
Columbia University248 enrolled2 locationsNCT05398185
Recruiting
Not Applicable
MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM
HIV/AIDS
Columbia University500 enrolled1 locationNCT06741618
Recruiting
Phase 2
Improving Physical Ability and Cellular Senescence Elimination in HIV
FrailtyHIVAging Problems+1 more
National Institute of Allergy and Infectious Diseases (NIAID)80 enrolled27 locationsNCT07144293
Recruiting
Phase 1Phase 2
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
HIVNon-HIVVagus Nerve Dysfunction
Icahn School of Medicine at Mount Sinai207 enrolled1 locationNCT04353778
Recruiting
Phase 1
Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)40 enrolled7 locationsNCT06665646
Recruiting
Phase 1
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
HIV InfectionRecurrent Non-Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma+12 more
AIDS Malignancy Consortium20 enrolled5 locationsNCT05077527
Recruiting
Phase 1Phase 2
Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1
HIV-1-infection
National Institute of Allergy and Infectious Diseases (NIAID)36 enrolled12 locationsNCT06071767
Recruiting
Not Applicable
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
HIV InfectionTobacco-Related Carcinoma
AIDS Malignancy Consortium100 enrolled11 locationsNCT04949464
Recruiting
Phase 2
A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV
HIV
National Institute of Allergy and Infectious Diseases (NIAID)200 enrolled21 locationsNCT06812494
Recruiting
Phase 1
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
HIV Infections
ViiV Healthcare100 enrolled41 locationsNCT07053384
Recruiting
Phase 2
A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaStage III High Grade B-Cell Lymphoma+7 more
Memorial Sloan Kettering Cancer Center50 enrolled7 locationsNCT06736613
Recruiting
Phase 2
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
Acute HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID)48 enrolled36 locationsNCT05719441
Recruiting
Phase 1
Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health
HIV
National Institute of Allergy and Infectious Diseases (NIAID)42 enrolled6 locationsNCT06796686
Recruiting
Not Applicable
Stick2PrEP Cisgender Women and Trans Individuals
HIV PreventionPre-exposure Prophylaxis
Columbia University175 enrolled1 locationNCT05165745
Recruiting
Not Applicable
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
Substance Use DisordersOpioid-use DisorderHepatitis C+1 more
Columbia University418 enrolled1 locationNCT03135886